Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Typhoid Vaccine Effect on Emotion in MDD
NCT03523767Phase 1Terminated
- Sponsor
- UTHealth Houston
- Start
- Feb 2018
- Primary completion
- Feb 2020
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of salmonella typhi capsular polysaccharide vaccine (2 arms), sponsored by UTHealth Houston. Primary endpoints: Change in Inflammation as indicated by cytokines, Change in depressed mood as indicated by Hamilton Depression Rating Scale (HAM-D) score and 1 more. Started Feb 2018; status: terminated.
02
Drugs
salmonella typhi capsular polysaccharide vaccine
Beyond the preview
Go deeper on NCT03523767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03523767.